Bristol Myers Squibb Co. Stock Outperforms Market Despite Losses On The Day
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Bristol Myers Squibb Co. (BMY) slumped 0.58% to $72.03 Monday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index falling 1.30% to 4,017.77 and Dow Jones Industrial Average falling 0.77% to 33,717.09. This was the stock's third consecutive day of losses. Bristol Myers Squibb Co. closed $9.41 short of its 52-week high ($81.44), which the company reached on December 1st.
The stock demonstrated a mixed performance when compared to some of its competitors Monday, as Johnson & Johnson (JNJ) fell 3.70% to $162.00, Pfizer Inc. (PFE) fell 0.55% to $43.55, and Abbott Laboratories (ABT) fell 0.13% to $109.81. Trading volume (6.8 M) remained 1.8 million below its 50-day average volume of 8.6 M.
Data source: Dow Jones Market Data, FactSet. Data compiled Janurary 30, 2023.
(END) Dow Jones Newswires
January 30, 2023 16:42 ET (21:42 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.